This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Flynn has been directly involved in the field of ADHD for over fourteen years.

ADHD is a behavioural syndrome characterized by hyperactivity, impulsivity, and inattention. It frequently goes undiagnosed and is commonly misunderstood. Today ADHD is firmly recognised as a lifelong condition, and while previously believed to be associated exclusively with childhood, it is clear that the condition can persist, or emerge in adulthood, continuing to present unique challenges for the individual, often with detrimental effects on their personal outcomes.
Flynn Pharma is committed to the delivery of high quality educational events that support the continued development of healthcare professionals – it's our way of helping you to help your patients. Don't miss out. Throughout 2023 and going forward, Flynn will host a series of educational events that are free to attend. Sign up to receive details of our latest updates.

Intellectual Disabilities and ADHD

We are delighted to invite you to join us for our webinar with speaker Dr Sunil Palapaka. He will discuss how to understand intellectual disability and how this differs from learning disability. He will also cover the impact ADHD has on children with intellectual disabilities and review the strategies and solutions to overcome these common challenges.
Wednesday 11 December 2024 at 12:30

Become an NDD Community Member

Join our community as a Member and keep up to date on the latest developments.

Flynn works across a number of complex yet treatable therapy areas and is committed to supporting the continued education of healthcare professionals, trainees and allied roles.

Information for Parents of Children Prescribed Meflynate® XL (Methylphenidate Hydrochloride)

Information for parents of children prescribed Meflynate XL - a general guide to treatment with Meflynate XL.

How to Make a Move to Secondary School

Support for children with ADHD moving to secondary school, providing tips for children and parents to make this change as easy as possible.

ADHD and ASD

Information for parents of children who may have characteristics or symptoms suggestive of ADHD and/or ASD.

Request a meeting

Send a virtual meeting request

Flynn has collaborated with clinicians and leaders working within the NHS and the third sector to create a range of patient-focused resources and materials designed to improve decision-making and support service improvement across a number of therapy areas.